Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorHospital for Special Surgery, New York
About this trial
The goal of this interventional clinical trial is to assess opioid consumption 24-48 hrs post anesthesia block among patients undergoing total knee arthroplasty. The main question it aims to answer is:
1\. Is there a difference in opioid consumption 24-48 hours post block administration among patients that receive an adductor canal catheter (ACC) versus adductor canal block (ACB)?
Participants will be:
* Randomized to receive an adductor canal catheter (ACC) or a sham adductor canal catheter. * Asked to use the Diagnotes application to communicate with the pain doctor while the catheter is in place. * Follow up for up to 6 months post-operation. Researchers will compare the interventional group (ACC) to the control group (sham ACC + ACB) to see if there is difference in opioid consumption and chronic pain at 6 months post-operation.
Eligibility criteria
Qualifiers
Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon
Age 18 to 75 years
Planned use of regional anesthesia
Ability to follow study protocol
Disqualifiers
Hepatic or renal insufficiency
Younger than 18 years old and older than 65
Patients undergoing general anesthesia
Allergy or intolerance to one of the study medications
Trial design
Treatments tested in this trial
- ambIT pump with catheter
- ambIT pump with sham catheter
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov